The Division of Neonatal-Perinatal Medicine provides comprehensive care for premature and full-term infants with a complex of neonatal problems. The ICN is a major referral center for term infants with respiratory failure and persistent pulmonary hypertension, perinatal asphyxia, extracorporeal membrane oxygenation (ECMO) and complex surgical problems, especially those with congenital diaphragmatic hernia where the survival for uncomplicated cases is greater than 90%. Special services offered in our nursery include high frequency ventilation, nitric oxide, hypothermia for perinatal asphyxia, and comprehensive neonatal health care. We also provide long-term neurodevelopmental follow-up for high-risk infants who are discharged from the intensive care nursery. The Division of Neonatal-Perinatal Medicine is a member of the National Institute of Child Health and Human Development (NICHD) Neonatal Research Network, a consortium of the leading neonatal intensive care units in the country that perform cutting-edge, collaborative clinical research.
The Division benchmarks patient care outcomes with this group of 16 of the leading intensive care nurseries in the country. Our low birth weight mortality and rate of broncho-pulmonary dysplasia and retinopathy of prematurity are consistently among the lowest.
The Division of Neonatal-Perinatal Medicine offers a NICHD sponsored fellowship program for pediatricians interested in advanced training in neonatal basic or clinical research. The Division houses the Jean & George Brumley Jr., Neonatal-Perinatal Research Institute which includes over 80 investigators at Duke interested in developmental biology and problems of the neonate and fetus.
Our expertise includes a continuum of care:
We offer:
Our Division provides comprehensive coverage for nurseries at Duke Hospital, Durham Regional and Alamance Regional Hospital:
| Name | Areas of Special Interest |
|---|---|
| Patricia L. Ashley, MD, PhD | Convalescent care of chronically ill neonates; acute care of mild to moderately ill newborns |
| Kamlesh V. Athavale, MD, MBBS | Prematurity, bronchopulmonary dysplasia, neonatal ventilation |
| Richard L. Auten, MD | Critically ill newborns, newborns with congenital malformations, severe respiratory failure, ECMO, high-frequency ventilation, nitric oxide |
| Margarita Bidegain, MD, MHS-CL | High-risk neonatal care, prenatal, neonatal and pediatric palliative care |
| C. Michael Cotten, MD, MHS | Optimizing care for newborns with evidence-based practice; special interest in infectious disease in low birth-weight infants, perinatal asphyxia, congenital diaphragmatic hernia, and the genomic approach to neonatal diseases |
| Jeffrey M. Ferranti, MD, MS | Medical informatics, computerized patient-safety initiatives, quality improvement metrics, electronic research data exchange, medical-data standards and interoperability, neonatal critical care, CPOE, electronic medical records |
| Ronald N. Goldberg, MD | Care of the low birth-weight infant, perinatal asphyxia, persistent pulmonary hypertension, congenital diaphragmatic hernia |
| Ricki F. Goldstein, MD | Neonatal intensive care, neuro-developmental follow-up of high-risk infants |
| Susan D. Izatt, MD | Intensive and transitional care of the ill newborn, neonatal skin, resident education |
| Robert W. Lenfestey, MD | Pediatric pharmacology, neuroprotection of very low birth-weight infants |
| William F. Malcolm, MD | Duke Transitional Care Nursery; convalescent and follow-up care of high-risk infants |
| Hugo A. Navarro, MD | Care of the critically ill neonate with special interest in respiratory disorders |
| P. Brian Smith, MD, MHS | Nosocomial infections in preterm neonates, drug safety and efficacy in neonates |
| David T. Tanaka, MD | High-risk neonatal care, financial process analysis |
| Yui-Lin Tang, MD, MHS | High-risk neonatal care, developmental care |
| James L. Wynn, MD | Care of premature and critically ill infants, neonatal sepsis, immunology and immunomodulation, physician teaching and development |
| Name | Areas of Special Interest |
|---|---|
| Richard L. Auten, MD | Mechanisms by which oxidative stress disrupts postnatal lung development in premature newborns. |
| Margarita Bidegain, MD, MHS | Palliative care. |
| C. Michael Cotten, MD, MHS |
Use of cord blood therapy for perinatal asphyxia, use of genomic studies to diagnose and guide neonatal therapy. |
| Jeffrey Ferranti, MD, MS | Use of medical informatics, computerized patient safety initiatives. |
| Ronald Goldberg, MD |
Perinatal asphyxia, use of stem cell/cord blood therapy for perinatal asphyxia. |
| Mary Hutson, PhD | Growth factor signalling and cardiac development. |
| Margaret Kirby, PhD | Etiology and pathogenesis of congential heart defects. |
| Chay Kuo, MD, PhD |
Neurodevelopmental research of neural stem cells. |
| William Malcolm, MD |
Diagnosis and management of gastroesophageal reflux. |
| David Tanaka, MD | Health care economics. |
| Name | Position |
|---|---|
| C. Michael Cotten, MD, MHS |
Medical Director |
| Kimberley Fisher, PhD, FNP-BC, IBCLC |
Director of Operations |
| Name | Position |
|---|---|
| Malissa Dunn, RRT |
Clinical Research Nurse |
| Katherine Foy, RN |
Clinical Research Coordinator, Neonatal Research Network |
| Sandra Grimes, RN, BSN | Coordinator of Industry and Investigator Research |
| Charles Vajdl | Clinical Trials Assistant |
| Name | Position |
|---|---|
| Jennifer McLamb |
Patient Services |
| Emily Patterson |
Patient Services |
Referrals 24/7: 800-MED-DUKE (800-633-3853) or call the Intensive Care Nursery directly and ask to speak to the fellow or attending on call: 919-681-5551
Urgent calls during business hours: 919-681-5551
Duke Children's